For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Adma Biologics Inc’s stock clocked out at $20.63, up 5.58% from its previous closing price of $19.54. In other words, the price has increased by $5.58 from its previous closing price. On the day, 2.2 million shares were traded. ADMA stock price reached its highest trading level at $20.65 during the session, while it also had its lowest trading level at $19.29.
Ratios:
To gain a deeper understanding of ADMA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 56.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 61.43. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 7.09. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 09 ’24 when Guiheen Lawrence P. sold 9,000 shares for $18.47 per share. The transaction valued at 166,189 led to the insider holds 153,941 shares of the business.
Guiheen Lawrence P. bought 9,000 shares of ADMA for $146,340 on Sep 09 ’24. On Aug 30 ’24, another insider, Kestenberg-Messina Kaitlin M., who serves as the COO and SVP, Compliance of the company, sold 24,150 shares for $16.90 each. As a result, the insider received 408,050 and left with 449,088 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 4876725248 and an Enterprise Value of 4901407744. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 74.67, and their Forward P/E ratio for the next fiscal year is 28.36. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.73. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.74 while its Price-to-Book (P/B) ratio in mrq is 21.03. Its current Enterprise Value per Revenue stands at 12.804 whereas that against EBITDA is 38.933.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $3.60. The 50-Day Moving Average of the stock is 10.72%, while the 200-Day Moving Average is calculated to be 71.73%.
Shares Statistics:
It appears that ADMA traded 5.16M shares on average per day over the past three months and 4170890 shares per day over the past ten days. A total of 236.39M shares are outstanding, with a floating share count of 228.41M. Insiders hold about 3.38% of the company’s shares, while institutions hold 89.70% stake in the company. Shares short for ADMA as of 1730332800 were 15198480 with a Short Ratio of 2.94, compared to 1727654400 on 17079555. Therefore, it implies a Short% of Shares Outstanding of 15198480 and a Short% of Float of 6.6199996.
